Skip to content

Binocular Amblyopia Treatment

Binocular Amblyopia Treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03288948
Enrollment
120
Registered
2017-09-20
Start date
2017-08-31
Completion date
2026-12-31
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Brief summary

To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.

Detailed description

To date, all studies of contrast-rebalanced binocular amblyopia treatment games used the same 10% per day contrast-increment that was designed for short-term intervention studies lasting 1-4 weeks; i.e., after 18 days of successful game play, both eyes viewed 100% contrast (no contrast-rebalancing).This study will investigate two alternative protocols designed to extend the game treatment period beyond 4 weeks to allow for more complete recovery of visual acuity. The new protocols will be compared with the original 10% contrast-increment game protocol in an 8-week 3-arm RCT to determine whether one or both of the new protocols is more effective than the current 10% increment. Based on pilot data, we expect about 40% of amblyopic children to achieve normal visual acuity in 8 weeks. In an effort to also promote recovery of binocular vision, children who attain ≤0.4 logMAR at 8 weeks will be enrolled in stereoacuity training at the 8-week visit for the next 4 weeks. Children with residual amblyopia (BCVA \>0.4 logMAR) at the 8-week visit will be provided with dichoptic movies for additional amblyopia treatment for another 4 weeks.

Interventions

OTHERBinocular games for treatment of amblyopia

playing binocular games on a tablet platform 1 hour per day 5 days per week with reduced contrast for the fellow eye and high contrast for the amblyopic eye

Sponsors

Retina Foundation of the Southwest
Lead SponsorOTHER
National Eye Institute (NEI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* age 4-10 y * male and female * strabismic, anisometropic, or combined mechanism amblyopia * amblyopic eye best-corrected visual acuity 0.3-0.8 logMAR * fellow eye best-corrected visual acuity ≤0.1 logMAR * interocular visual acuity difference ≥0.3 logMAR * wearing glasses (if needed) for 8 weeks or no change visual acuity with glasses at 2 visits * 4 weeks apart. * child's ophthalmologist and family must be willing to forgo patching treatment during the 12-week study period * parent's informed consent * child must demonstrate understanding and ability to play binocular games

Exclusion criteria

* prematurity ≥8 weeks * coexisting ocular or systemic disease * developmental delay * strabismus \>5pd * any binocular amblyopia treatment in the past 3 months

Design outcomes

Primary

MeasureTime frameDescription
Change in visual acuity of the amblyopic eyebaseline vs 8 weeksATS-HOTV for age 4-6.9 years or E-ETDRS for age 7-10.9 years

Secondary

MeasureTime frameDescription
Change in visual acuity of the amblyopic eyebaseline vs 2, 4, 6, and 12 weeksATS-HOTV for age 4-6.9 years or E-ETDRS for age 7-10.9 years
Change in stereoacuitybaseline vs 2, 4, 6, 8, 12 weeksRandot Preschool Stereoacuity Test
Change in suppressionbaseline vs 2, 4, 6, 8, 12 weeksDichoptic Letter Chart

Countries

United States

Contacts

CONTACTReed Jost, MS
reedjost@retinafoundation.org2143633911
CONTACTKrista Kelly, PhD
kkelly@rfsw.org2143633911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026